Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.
about
Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureLocalization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells.Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis.Development potential of rifalazil and other benzoxazinorifamycins.The role of the vascular dendritic cell network in atherosclerosis.Human antibody responses to a Chlamydia-secreted protease factorChlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species.The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cellsChlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.
P2860
Q33716094-1641004E-7B4A-491C-87B8-FDB41B748DA9Q33916075-165A25EB-EAA2-4729-B178-ACF5A6BDC077Q34116447-C9636D1E-2776-40E4-AD65-A7776714A0CBQ35127516-0224F33B-BB26-48B0-ADCB-A4D42BB0A0C7Q35217607-500EF53F-7001-4543-AD2C-67809DDD5A3CQ35688972-BEB56AC5-77C3-43F0-9676-3184B2CF3DE9Q36011463-7BF6FF4A-927D-4D07-B94E-606C33DEEB9EQ36376749-07470E08-D88A-4812-BC17-BF964188D882Q36491823-539A0411-7519-4F9A-97D5-B244C243F7B6Q37050929-CD974998-DA8A-4114-971E-81FCD19FAC88Q37623832-27E6185C-56C2-49BC-90AE-7EFCCB291B06Q37849579-A7A41B8B-8D8E-4F72-8A42-3189647747A7Q37857559-8092B3A5-2343-4414-B3C7-A86AB6E312FFQ37860795-1568CD62-1197-401A-AD11-FA1092438A35Q37870924-541DCD93-30C7-45CE-80A0-DB1FBB62CD33Q55038629-6B3D8E80-5CE2-45E2-8EA3-BE7BAB5B6330
P2860
Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia pneumoniae infection ...... mouse model within six months.
@en
Chlamydia pneumoniae infection ...... mouse model within six months.
@nl
type
label
Chlamydia pneumoniae infection ...... mouse model within six months.
@en
Chlamydia pneumoniae infection ...... mouse model within six months.
@nl
prefLabel
Chlamydia pneumoniae infection ...... mouse model within six months.
@en
Chlamydia pneumoniae infection ...... mouse model within six months.
@nl
P2093
P356
P1476
Chlamydia pneumoniae infection ...... mouse model within six months
@en
P2093
P2888
P304
P356
10.1023/A:1026531506202
P577
2000-12-01T00:00:00Z
P6179
1003735312